Table 4.
Pre-pandemic ICU |
Covid-19 ICU |
Total |
p | ||||
---|---|---|---|---|---|---|---|
S | R | S | R | S | R | ||
AK | 14 (53.8) | 12 (46.2) | 5 (55.6) | 4 (44.4) | 19 (54.3) | 16 (45.7) | 0.999 |
GN | 17 (63) | 10 (37) | 5 (55.6) | 4 (44.4) | 22 (61.1) | 14 (38.9) | 0.712 |
COL | 19 (90.5) | 2 (9.5) | 4 (57.1) | 3 (42.9) | 23 (82.1) | 5 (17.9) | 0.082 |
MEM | 7 (35) | 13 (65) | 2 (28.6) | 5 (71,.4) | 9 (33.3) | 18 (66.7) | 0.999 |
ETP | 10 (38.5) | 16 (61.5) | 2 (28.6) | 5 (71.4) | 12 (36.4) | 21 (63.6) | 0.999 |
AMC | 5 (22.7) | 17 (77.3) | 1 (20) | 4 (80) | 6 (22.2) | 21 (77.8) | 0.999 |
TPZ | 7 (29.2) | 17 (70.8) | 2 (22,2) | 7 (77.8) | 9 (27.3) | 24 (72.7) | 0.999 |
CAZ | 2 (9.5) | 19 (90.5) | 1 (11.1) | 8 (88.9) | 3 (10) | 27 (90) | 0.999 |
CİP | 7 (30.4) | 16 (69.6) | 0 (0) | 9 (100) | 7 (21.9) | 25 (78.1) | 0.149 |
TGC | 18 (69.2) | 8 (30.8) | 6 (66.7) | 3 (33.3) | 24 (68.6) | 11 (31.4) | 0.999 |
SXT | 6 (27.3) | 16 (72.7) | 3 (33.3) | 6 (66.7) | 9 (29) | 22 (71) | 0.999 |
FEP | 6 (24) | 19 (76) | 2 (22.2) | 7 (77.8) | 8 (23.5) | 26 (76.5) | 0.999 |
p < 0.05 significant relationship, p > 0.05 no significant relationship; Chi-square test.
AK: amikacin, GN: gentamicin, COL: colistin, MEM: meropenem, ETP: ertapenem, AMC: amoxicillin clavulanic acid, TPZ: piperacillin tazobactam, CAZ: ceftazidime, CIP: ciprofloxacin, TGC: tigecycline, SXT: trimethoprim, sulfamethoxazole, FEP: cefepime.